<DOC>
	<DOCNO>NCT01397279</DOCNO>
	<brief_summary>Type 2 diabetes associate hepatic insulin resistance . One consequence insulin resistance liver alter hepatic glucose metabolism . This study investigate whether whole body ( M-value ) hepatic insulin sensitivity obtain hyperinsulinemic euglycemic clamp influence precede intravenous glucose tolerance test ( Botnia Clamp ) subject type 2 diabetes .</brief_summary>
	<brief_title>Assessment Liver Glucose Metabolism Diabetic Subjects</brief_title>
	<detailed_description>The hyperinsulinemic euglycemic clamp represent gold standard measure peripheral insulin sensitivity . The insulin sensitivity describe M-value , calculate glucose infusion rate last 30min clamp . Glucose metabolise periphery : 50 % neural tissue , 20 % splanchnic bed liver , 15 % skeletal muscle , 5 % adipose tissue 10 % blood cell tissue . Under hyperinsulinemic condition strong shift glucose utilization : 85 % skeletal muscle 15 % neural tissue , splanchnic bed liver , adipose tissue , blood cell tissue . The contribution skeletal muscle varies different insulin sensitivity . We want investigate whether difference tissue-specific insulin sensitivity measure Botnia clamp ( intravenous glucose tolerance test ( ivGTT ) follow clamp ) single hyperinsulinemic euglycemic clamp ? After 60min ivGTT blood glucose level type 2 diabetic subject still elevate compare baseline . High blood glucose level influence several parameter may also affect insulin sensitivity . Until , proven , clamp precede ivGTT significant influence M-value .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>newly diagnose type 2 diabetes ( last 12 month ) nondiabetic subject severe chronic disease hepatitis B , C oder HIV infection malignancy immune suppressive therapy psychiatric illness drug alcohol abuse anemia renal dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>hyperinsulinemic euglycemic clamp</keyword>
</DOC>